• Birdwell, L.D., Zalinger, Z.B., Li, Y., Wright, P.W., Elliott, R., Rose, K.M., Silverman, R.H., Weiss, S.R., 2016. Activation of rnase l by murine coronavirus in myeloid cells is dependent on basal oas gene expression and independent of virus-induced interferon.J. Virol. 90, 3160-3172.

  • Chebath, J., Benech, P., Revel, M., Vigneron, M., 1987. Constitutive expression of (2'-5') oligo a synthetase confers resistance to picornavirus infection. Nature 330, 587-588.

  • Choi, U.Y., Kang, J.S., Hwang, Y.S., Kim, Y.J., 2015. Oligoadenylate synthase-like (oasl) proteins:dual functions and associations with diseases. Exp. Mol. Med. 47, e144.

  • Coccia, E.M., Romeo, G., Nissim, A., Marziali, G., Albertini, R., Affabris, E., Battistini, A., Fiorucci, G., Orsatti, R., Rossi, G.B., et al., 1990. A full-length murine 2-5a synthetase cdna transfected in nih-3t3 cells impairs emcv but not vsv replication. Virology 179, 228-233.

  • Floyd-Smith, G., 1988. (2'-5')an-dependent endoribonuclease:enzyme levels are regulated by ifn beta, ifn gamma, and cell culture conditions. J. Cell. Biochem. 38, 13-21.

  • Floyd-Smith, G., Denton, J.S., 1988. A (2'-5')an-dependent endonuclease:tissue distribution in balb/c mice and the effects of ifn-beta treatment and anti-ifn-alpha/beta immunoglobulin on the levels of the enzyme. J. Interferon Res. 8, 517-525.

  • Ghosh, A., Sarkar, S.N., Sen, G.C., 2000. Cell growth regulatory and antiviral effects of the p69 isozyme of 2-5 (a) synthetase. Virology 266, 319-328.

  • Gough, D.J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A.C., Levy, D.E., 2009. Mitochondrial stat3 supports ras-dependent oncogenic transformation. Science 324, 1713-1716.

  • Ho, H.H., Ivashkiv, L.B., 2006. Role of stat3 in type i interferon responses. Negative regulation of stat1-dependent inflammatory gene activation. J. Biol. Chem. 281, 14111-14118.

  • Huang, H.I., Lin, J.Y., Chen, S.H., 2019. Ev71 infection induces ifnβ expression in neural cells. Viruses 11, 1121.

  • Ibsen, M.S., Gad, H.H., Thavachelvam, K., Boesen, T., Desprès, P., Hartmann, R., 2014. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for rnase l activation. J. Virol. 88, 14222-14231.

  • Ivashkiv, L.B., Donlin, L.T., 2014. Regulation of type i interferon responses. Nat. Rev.Immunol. 14, 36-49.

  • Jacobsen, H., Czarniecki, C.W., Krause, D., Friedman, R.M., Silverman, R.H., 1983. Interferon-induced synthesis of 2-5a-dependent rnase in mouse jls-v9r cells. Virology 125, 496-501.

  • Kandolf, R., Canu, A., Hofschneider, P.H., 1985. Coxsackie b3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17, 167-181.

  • Koestner, W., Spanier, J., Klause, T., Tegtmeyer, P.K., Becker, J., Herder, V., Borst, K., Todt, D., Lienenklaus, S., Gerhauser, I., Detje, C.N., Geffers, R., Langereis, M.A., Vondran, F.W.R., Yuan, Q., van Kuppeveld, F.J.M., Ott, M., Staeheli, P., Steinmann, E., Baumgärtner, W., Wacker, F., Kalinke, U., 2018. Interferon-beta expression and type i interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in coxsackievirus b3-infected mice. PLoS Pathog. 14, e1007235.

  • Kristiansen, H., Gad, H.H., Eskildsen-Larsen, S., Despres, P., Hartmann, R., 2011. The oligoadenylate synthetase family:an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 31, 41-47.

  • Kuchipudi, S.V., 2015. The complex role of stat3 in viral infections. J Immunol Res 2015, 272359.

  • Li, Y., Banerjee, S., Wang, Y., Goldstein, S.A., Dong, B., Gaughan, C., Silverman, R.H., Weiss, S.R., 2016. Activation of rnase l is dependent on oas3 expression during infection with diverse human viruses. Proc. Natl. Acad. Sci. U. S. A. 113, 2241-2246.

  • Lu, J., Yi, L., Ke, C., Zhang, Y., Liu, R., Chen, J., Kung, H.F., He, M.L., 2015. The interaction between human enteroviruses and type i ifn signaling pathway. Crit. Rev. Microbiol. 41, 201-207.

  • Mahony, R., Gargan, S., Roberts, K.L., Bourke, N., Keating, S.E., Bowie, A.G., O'Farrelly, C., Stevenson, N.J., 2017. A novel anti-viral role for stat3 in ifn-α signalling responses. Cell. Mol. Life Sci. 74, 1755-1764.

  • Marié, I., Rebouillat, D., Hovanessian, A.G., 1999. The expression of both domains of the 69/71 kda 2',5' oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur. J. Biochem. 262, 155-165.

  • Mathelier, A., Fornes, O., Arenillas, D.J., Chen, C.Y., Denay, G., Lee, J., Shi, W., Shyr, C., Tan, G., Worsley-Hunt, R., Zhang, A.W., Parcy, F., Lenhard, B., Sandelin, A., Wasserman, W.W., 2016. Jaspar 2016:a major expansion and update of the openaccess database of transcription factor binding profiles. Nucleic Acids Res. 44, D110-D115.

  • Matys, V., Fricke, E., Geffers, R., Gössling, E., Haubrock, M., Hehl, R., Hornischer, K., Karas, D., Kel, A.E., Kel-Margoulis, O.V., Kloos, D.U., Land, S., Lewicki-Potapov, B., Michael, H., Münch, R., Reuter, I., Rotert, S., Saxel, H., Scheer, M., Thiele, S., Wingender, E., 2003. Transfac:transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374-378.

  • Rasti, M., Khanbabaei, H., Teimoori, A., 2019. An update on enterovirus 71 infection and interferon type i response. Rev. Med. Virol. 29, e2016.

  • Roca Suarez, A.A., Van Renne, N., Baumert, T.F., Lupberger, J., 2018. Viral manipulation of stat3:evade, exploit, and injure. PLoS Pathog. 14, e1006839.

  • Rysiecki, G., Gewert, D.R., Williams, B.R., 1989. Constitutive expression of a 2',5'-oligoadenylate synthetase cdna results in increased antiviral activity and growth suppression. J. Interferon Res. 9, 649-657.

  • Samuel, C.E., 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809.

  • Schoggins, J.W., Rice, C.M., 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1, 519-525.

  • Stark, G.R., Darnell Jr., J.E., 2012. The jak-stat pathway at twenty. Immunity 36, 503-514.

  • Su, R., Shereen, M.A., Zeng, X., Liang, Y., Li, W., Ruan, Z., Li, Y., Liu, W., Liu, Y., Wu, K., Luo, Z., Wu, J., 2020. The tlr3/irf1/type iii ifn axis facilitates antiviral responses against enterovirus infections in the intestine. mBio 11, e02540-20.

  • Swain, S.K., Gadnayak, A., Mohanty, J.N., Sarangi, R., Das, J., 2022. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion. Rev. Med. Virol. e2322.

  • Tan, G., Xu, F., Song, H., Yuan, Y., Xiao, Q., Ma, F., Qin, F.X., Cheng, G., 2018. Identification of trim14 as a type i ifn-stimulated gene controlling hepatitis b virus replication by targeting hbx. Front. Immunol. 9, 1872.

  • Tsai, M.H., Lee, C.K., 2018. Stat3 cooperates with phospholipid scramblase 2 to suppress type i interferon response. Front. Immunol. 9, 1886.

  • Wan, J., Fu, A.K.Y., Ip, F.C.F., Ng, H.-K., Hugon, J., Page, G., Wang, J.H., Lai, K.-O., Wu, Z., Ip, N.Y., 2010. Tyk2/stat3 signaling mediates β-amyloid-induced neuronal cell death:implications in alzheimer's disease. J. Neurosci. 30, 6873-6881.

  • Wang, H., Yuan, M., Wang, S., Zhang, L., Zhang, R., Zou, X., Wang, X., Chen, D., Wu, Z., 2019. Stat3 regulates the type i ifn-mediated antiviral response by interfering with the nuclear entry of stat1. Int. J. Mol. Sci. 20, 4870.

  • Wang, W.B., Levy, D.E., Lee, C.K., 2011. Stat3 negatively regulates type i ifn-mediated antiviral response. J. Immunol. 187, 2578-2585.

  • Xu, N., Yang, J., Zheng, B., Zhang, Y., Cao, Y., Huan, C., Wang, S., Chang, J., Zhang, W., 2020. The pyrimidine analog fnc potently inhibits the replication of multiple enteroviruses. J. Virol. 94, e00204-e00220.

  • Yi, L., He, Y., Chen, Y., Kung, H.F., He, M.L., 2011. Potent inhibition of human enterovirus 71 replication by type i interferon subtypes. Antivir. Ther. 16, 51-58.

  • Zhou, X., Tian, L., Wang, J., Zheng, B., Zhang, W., 2022. Ev71 3c protease cleaves host anti-viral factor oas3 and enhances virus replication. Virol. Sin. 37, 418-426.